Industry News
Student awards need a saviour
The annual Student Excellence Awards, which support Australian students in bioscience research with reward and recognition, are in need of an industry sponsor if they are to go ahead this year. [ + ]
Mapping the developing mind
Comprehensive mapping of the human brain epigenome has revealed patterns of methylation that occur during the formation of brain circuitry. [ + ]
Supporting industry innovation
The $70,000 Australian Innovation Challenge awards are now open and seeking great ideas from Australians. [ + ]
NZ/UK collaboration for rapid point-of-care diagnostics
New Zealand biomarker research company BioTest Diagnostics is collaborating with UK diagnostics development company AgPlus to bring immediate point-of-care testing benefits to the veterinary market. [ + ]
Eyes in their stars: starfish and eye evolution
A study has shown for the first time that starfish use primitive eyes at the tip of their arms to visually navigate their environment. [ + ]
iSonea raises $13.5m to fund AirSonea launch
iSonea (ASX:ISN) has raised $13.5m in a placement to help pay the manufacturing, distribution and marketing costs of the upcoming launch of mobile wheeze-monitoring device AirSonea. [ + ]
Bioniche closes funding, licensing deal with Paladin
Bioniche (ASX:BNC) has gained access to a further C$5m in funding after closing its debt refinancing and Urocidin licensing deal with Paladin Labs. [ + ]
Novogen gets up to $5m to fund CS-6 development
Novogen (ASX:NRT) has signed a deal with a US investor that will give it access to up to $5m in working capital to help take cancer drug candidate CS-6 into the clinic. [ + ]
The Australian Innovation Challenge 2013 is now open
The quest for the nation’s best ideas - in fields from minerals and energy to community services - resumes today through the $70,000 The Australian Innovation Challenge awards. [ + ]
Assay to ensure drugs reach their targets
Researchers at Karolinska Institutet in Sweden have developed the first method for directly measuring the extent to which drugs reach their targets in the cell. [ + ]
Why do antibiotics have side effects?
Over the years, doctors have prescribed antibiotics freely, thinking that they harm bacteria while leaving human tissue unscathed. But as scientists at Harvard University’s Wyss Institute for Biologically Inspired Engineering have noted, “Prolonged antibiotic treatment can lead to detrimental side effects in patients, including ototoxicity, nephrotoxicity and tendinopathy.” [ + ]
Novel chemistry for new class of antibiotic
University of Adelaide research has produced a potential new antibiotic which could help in the battle against bacterial resistance to antibiotics. [ + ]
Cheap antifreeze materials may lead to low-cost solar energy
A process combining some comparatively cheap materials and the same antifreeze that keeps an automobile radiator from freezing in cold weather may be the key to making solar cells that cost less and avoid toxic compounds. [ + ]
Prima doubles active sites for cancer vaccine trial
Prima BioMed (ASX:PRR) has started recruiting for its CANVAS ovarian cancer trial across four more European countries. [ + ]
HIV treatment could reach millions more people
HIV-positive people are likely to gain increased access to antiretroviral treatment thanks to research showing that a lower dose is as effective as the standard higher dose. [ + ]
